This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Feb 20;145(8):785-786.

doi: 10.1182/blood.2024027600.

A belt-and-suspenders approach to PNH

Gloria F Gerber¹, Robert A Brodsky¹

Affiliations

PMID: 39976947
DOI: 10.1182/blood.2024027600

Editorial

A belt-and-suspenders approach to PNH

Gloria F Gerber et al. Blood. 2025.

. 2025 Feb 20;145(8):785-786.

doi: 10.1182/blood.2024027600.

Authors

Gloria F Gerber¹, Robert A Brodsky¹

Affiliation

¹ Johns Hopkins University School of Medicine.

PMID: 39976947
DOI: 10.1182/blood.2024027600

No abstract available

PubMed Disclaimer

Comment on

Long-term efficacy and safety of danicopan as add-on therapy to ravulizumab or eculizumab in PNH with significant EVH.
Kulasekararaj A, Griffin M, Piatek C, Shammo J, Nishimura JI, Patriquin C, Schrezenmeier H, Barcellini W, Panse J, Gaya A, Patel Y, Liu P, Filippov G, Sicre de Fontbrune F, Risitano A, Lee JW. Kulasekararaj A, et al. Blood. 2025 Feb 20;145(8):811-822. doi: 10.1182/blood.2024026299. Blood. 2025. PMID: 39700502 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Silverchair Information Systems